ATE346865T1 - Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp - Google Patents

Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp

Info

Publication number
ATE346865T1
ATE346865T1 AT99966605T AT99966605T ATE346865T1 AT E346865 T1 ATE346865 T1 AT E346865T1 AT 99966605 T AT99966605 T AT 99966605T AT 99966605 T AT99966605 T AT 99966605T AT E346865 T1 ATE346865 T1 AT E346865T1
Authority
AT
Austria
Prior art keywords
monoclonal antibodies
cell type
present
specific cell
antigens
Prior art date
Application number
AT99966605T
Other languages
English (en)
Inventor
Jennie P Mather
Laura N Bald
Penelope R Roberts
Jean-Philippe F Stephan
Original Assignee
Raven Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raven Biotechnologies Inc filed Critical Raven Biotechnologies Inc
Application granted granted Critical
Publication of ATE346865T1 publication Critical patent/ATE346865T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99966605T 1998-12-22 1999-12-22 Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp ATE346865T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21853998A 1998-12-22 1998-12-22

Publications (1)

Publication Number Publication Date
ATE346865T1 true ATE346865T1 (de) 2006-12-15

Family

ID=22815514

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99966605T ATE346865T1 (de) 1998-12-22 1999-12-22 Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp

Country Status (11)

Country Link
US (1) US20040146990A1 (de)
EP (1) EP1141026B1 (de)
JP (2) JP2002538772A (de)
CN (1) CN1258539C (de)
AT (1) ATE346865T1 (de)
AU (1) AU776675B2 (de)
CA (1) CA2352471A1 (de)
DE (1) DE69934250T2 (de)
DK (1) DK1141026T3 (de)
HK (1) HK1041273B (de)
WO (1) WO2000037503A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR177400A0 (en) 2000-11-29 2000-12-21 Cancerprobe Pty Ltd Probes for identifying cancer-specific antigens
EP1480520A4 (de) 2002-02-12 2006-02-15 Raven Biotechnologies Inc Epithelzellen aus der human-fötalen blase
CN101155830B (zh) 2005-02-04 2014-06-18 雷文生物技术公司 结合epha2的抗体及其使用方法
EP2096166A1 (de) * 2005-03-31 2009-09-02 Osaka University Verfahren zur Herstellung von gegen das Zellmembranoberflächen-Antigenepitop gerichteten Antikörpern und Assay-Verfahren
NZ569791A (en) * 2005-12-16 2011-10-28 Larry Mark Weisenthal Microaggregates including endothelial cells for microscopic observation
US7943666B2 (en) * 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
WO2013040142A2 (en) 2011-09-16 2013-03-21 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
EP4012714A1 (de) 2010-03-23 2022-06-15 Iogenetics, LLC. Bioinformatikverfahren zur bestimmung von peptidbindungen
DE102010039018B4 (de) * 2010-08-06 2013-02-28 Technische Universität Dresden Anti-La Antikörper und ihre Anwendung zum Immunotargeting
JP2016513794A (ja) * 2013-03-06 2016-05-16 ゼネラル・エレクトリック・カンパニイ Ｈ＆ｅ染色された生体試料を分析する方法
US20190056390A1 (en) * 2016-02-24 2019-02-21 Sekisui Medical Co., Ltd. Method for detecting oncofetal fibronectin using immunochromatography

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487829A (en) * 1982-03-23 1984-12-11 Massachusetts Institute Of Technology Production and use of monoclonal antibodies against adenoviruses
US5364785A (en) * 1990-02-09 1994-11-15 Genentech, Inc. Method of isolating lung cell line
AU5611394A (en) * 1992-11-19 1994-06-08 Dana-Farber Cancer Institute Antibodies for gm-csf receptor and uses thereof
US5721139A (en) * 1995-05-10 1998-02-24 Genentech, Inc. Isolating and culturing schwann cells
US5714385A (en) * 1995-05-10 1998-02-03 Genentech, Inc. Media for culturing schwann cells
IL122233A (en) * 1996-12-06 2001-04-30 Akzo Nobel Nv Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them
US6004528A (en) * 1997-09-18 1999-12-21 Bergstein; Ivan Methods of cancer diagnosis and therapy targeted against the cancer stemline

Also Published As

Publication number Publication date
DE69934250D1 (de) 2007-01-11
JP4426627B2 (ja) 2010-03-03
CA2352471A1 (en) 2000-06-29
DE69934250T2 (de) 2007-05-24
EP1141026B1 (de) 2006-11-29
WO2000037503A1 (en) 2000-06-29
JP2009001562A (ja) 2009-01-08
DK1141026T3 (da) 2007-03-26
AU2211300A (en) 2000-07-12
CN1350549A (zh) 2002-05-22
JP2002538772A (ja) 2002-11-19
AU776675B2 (en) 2004-09-16
EP1141026A1 (de) 2001-10-10
HK1041273A1 (en) 2002-07-05
US20040146990A1 (en) 2004-07-29
HK1041273B (en) 2007-05-18
CN1258539C (zh) 2006-06-07

Similar Documents

Publication Publication Date Title
DK1414858T3 (da) Kamelid-enkeltkæde-VHH-antistoffer, fremgangsmåde til fremstilling heraf i et pattedyr samt anvendelser heraf
ATE439380T1 (de) Methoden zur herstellung humaner monoklonaler antikörper
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
DE60019111D1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
ES2171705T3 (es) Complejos de polipeptido-dendrimero.
DE69521794D1 (de) Zellen mit mehreren geänderten epitopen auf einem oberflächeantigen zur verwendung in transplantation
ATE346865T1 (de) Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp
ATE468390T1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
ATE227579T1 (de) Verfahren zur herstellung von makrophagen und ausrüstungen zur durchführung dieses verfahrens
ATE230020T1 (de) Katalytische antikörperkomponente
ATE279443T1 (de) A3c6e2, ein monoklonaler antikörper spezifisch für den humanen stammzellfaktor (scf)-rezeptor
PT1200561E (pt) Clone celular recombinante estavel, sua producao e utilizacao
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
GR3031607T3 (en) Selective system scan for multizone radiotelephone subscriber units.
DK1711531T3 (da) Neutraliserende anti-TLR4/-MD-2-antistoffer og fremgangsmåder til anvendelse deraf
CA2480717A1 (en) Method for producing monoclonal antibodies
ATE370163T1 (de) Antikörper zur isolierung und/oder identifizierung mesenchymaler stammzellen und verfahren zur isolierung und/oder identifizierung mesenchymaler stammzellen
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
ATA168387A (de) Verfahren zur herstellung von zellinien, die monoklonale antikörper produzieren
DE69505365D1 (de) Immunologisches verfahren zum nachweis von glykosaminoglykan-aktiviertem antithrombin iii; die entsprechenden monoklonalen antikörper und deren herstellung
LT2005053A (en) Method of obtaining cell lines in a protein-free medium and cell lines thus obtained
ATE132896T1 (de) Methoden zur verwendung von an humanen klasse-ii- histokompatibilitätsantigenen mangelnden zellinien
BRPI0409383A (pt) métodos para produção livre de hibridoma ex vivo de anticorpos policlonais e monoclonais e geração de populações de célula imortalizada
ATE125306T1 (de) Monoklonale antikörper, die einen unterschied zwischen nativproteinen und proteinen mit einer modifizierten sequenz machen.
MXPA02010471A (es) Metodo para la obtencion de lineas celulares en medio libre de proteina y lineas celulares obtenidas por este metodo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties